Skip to content

An open-label, low interventional clinical study investigating error rates (critical and overall) prior to any retraining in correct use of the ELLIPTA dry powder inhaler (DPI) compared to other DPIs including; DISKUS, Turbuhaler, HandiHaler and Breezhaler as a monotherapy or in combination, in adult patients with Chronic Obstructive Pulmonary Disease (COPD) (study 204981)

An open-label, low interventional clinical study investigating error rates (critical and overall) prior to any retraining in correct use of the ELLIPTA dry powder inhaler (DPI) compared to other DPIs including; DISKUS, Turbuhaler, HandiHaler and Breezhaler as a monotherapy or in combination, in adult patients with Chronic Obstructive Pulmonary Disease (COPD) (study 204981) - 204981

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON46129
Enrollment
360
Registered
2017-10-05
Start date
2017-06-29
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic obstructive airways disease (COPD)

Interventions

Demonstration of inhaler use. Corrective actions. Completion of CAT questionnaire.
COPD

Sponsors

GlaxoSmithKline
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: * *40 years of age. * COPD. * Currently receiving maintenance therapy with one of the treatments listed in table 1 of the protocol (page 17-18).

Exclusion criteria

Exclusion criteria: * Asthma. * Participants who have been trained during participation in any device study in the 6 months prior to entry into this study * Drug/alcohol abuse.

Design outcomes

Primary

MeasureTime frame
The percentage of participants making at least one critical error at V1 for each DPI tested.

Secondary

MeasureTime frame
The percentage of participants making at least one critical error at V2 for each DPI tested. The percentage of participants making at least one critical or overall error at V2 for each DPI tested.

Countries

Netherlands, United Kingdom

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)